Stock News
Get Ready to LOL: The Ultimate Guide to Surviving Awkward Social Situations
SpotlightAI™, Powered by AWS, Selected by UNDP for Hyperscale AI Analysis of Drone Imagery Addressing the Unprecedented Scope of the Landmine Crisis in Ukraine AVENTURA, FL / ACCESSWIRE / September 5, 2024 / Safe Pro Group Inc. (Nasdaq:SPAI) Safe Pro Group Inc. (Nasdaq:SPAI) Safe Pro Group Inc. (Nasdaq:SPAI), also known as Safe Pro, has made…
Experience the Excitement: Jackpot Digital Successfully Installs 4 Tables at Gold Country Casino Resort in California
Exciting News from Jackpot Digital Inc. New Electronic Table Games Installed at Gold Country Casino Resort Vancouver, British Columbia–(Newsfile Corp. – September 5, 2024) – Jackpot Digital Inc. (TSXV: JJ) (TSXV: JJ.WT.B) (TSXV: JJ.WT.C) (OTCQB: JPOTF) (FSE: LVH3) (the “Company” or “Jackpot”), a leading manufacturer of electronic multiplayer dealerless poker tables, is pleased to announce…
Sonida Set to Take the Stage at BofA Securities’ 2024 Global Real Estate Conference
Sonida Senior Living Announces Participation in BofA Securities 2024 Global Real Estate Conference Exciting Opportunity for Sonida Senior Living Sonida Senior Living, Inc. (“Sonida” or the “Company”) (NYSE: SNDA) has recently announced that Brandon Ribar, President and Chief Executive Officer, and Max Levy, Chief Investment Officer, will be participating in the BofA Securities 2024 Global…
Hoth Therapeutics Announces Positive Results from First-of-its-Kind Human Patient Treatment of EGFRi-Associated Skin Toxicities with HT-001
Cancer Patient Ceased Treatment After One Week Due to Rapid Success Overview In the reported case, the patient, a 59-year-old female undergoing treatment at George Washington University for metastatic breast cancer, experienced significant improvement in symptoms just one week after initiating HT-001 therapy. Due to the swift resolution of lesions and the alleviation of discomfort,…
Breaking News: Medera Inc. to Join NASDAQ via Merger with Keen Vision Acquisition Corporation
Medera: Revolutionizing Cardiovascular Disease Treatment Introduction Medera, a clinical-stage biotechnology company, is at the forefront of targeting difficult-to-treat cardiovascular diseases. Their focus on next-generation gene- and cell-based approaches, in combination with bioengineered human mini-heart drug discovery and screening technology platforms, sets them apart in the field of biotech innovation. Merger and Growth The recent merger…
Ridgeline Minerals Discovers High-Grade Copper and Gold at Big Blue Porphyry Project in Nevada
Ridgeline Minerals Corp Expands Big Blue Land Position High-grade Au Rock Chip Sample Reveals Visible Gold in Quartz Vein Induced Polarization Geophysics Survey Complete In a recent announcement, Ridgeline Minerals Corp has revealed that it has expanded its Big Blue land position by 23%, marking a significant milestone for the company. The expansion comes after…
Jacobs Solutions Stock: Q3 Shows Strong Backlog and Promising Growth for FY25
Jacobs Solutions: A Strong Buy with Backlog Growth and Spin-off Merger Nearing Completion of a Spin-off and Merger Jacobs Solutions has been making waves in the industry with its strong backlog growth and nearing completion of a spin-off and merger. As an investor, this is great news as it reinforces my ‘Strong Buy’ rating with…
Jazz Pharmaceuticals to Showcase Improved Epilepsy Outcomes with Epidiolex/Cannabidiol at European Epilepsy Congress 2024
Jazz Pharmaceuticals Announces Presentation of Data on Epidyolex® Treatment at European Epilepsy Congress DUBLIN, Sept. 5, 2024 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will present eight abstracts at the 15th European Epilepsy Congress (EEC), including results of the BECOME Caregiver Survey. The survey focuses on the real-world outcomes of Epidyolex® (cannabidiol) treatment on patients…